Related Experiment Video
Updated: Feb 5, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Quantitative characterization of 18F-PSMA-1007 and [68Ga]Ga-PSMA-11 PET-CT Imaging in Suspected Prostate Cancer: A
Bal Sanghera1, Gerry Lowe2, Sophie Sanghera3
1St. Barts Health Nhs Trust, Clinic of Nuclear Medicine, London, United Kingdom.
Objectives:
We record quantitative differences between 18F-prostate specific membrane antigen (18F-PSMA)-1007 and [68Ga]Ga-PSMA-11 positron emission tomography (PET) prostate scans at our centre to investigate if significant differences exist between suspected lesion and lesion/ background parameters studied. We also assess the potential impact of such differences on tracer interchangeability when supply is constrained.
Methods:
Sixty-one [68Ga]Ga-PSMA-11 and seventy-two 18F-PSMA-1007 patients were analysed in two cohorts, each comprising 200 lesions. Clinical reports were used to determine maximum standard uptake values (SUVmax) was recorded for suspected lesions (T). Similarly, normalisations of mean standardized uptake (SUVmean) and standardized uptake value-peak (SUVpeak) using lean body mass (SUVIbm) and body surface area (SUVbsa) were estimated. SUVmean of liver backgrounds (B) was recorded to estimate T/B ratios. Metabolic tumour volume and total lesion PSMA (TL-PSMA) were investigated as functional volume surrogates. The Mann-Whitney U test was used to identify significant differences between the [68Ga]Ga-PSMA-11 and 18F-PSMA-1007 distributions.
Results:
Significant differences were observed for lesion SUVmax (p=0.0004), SUVpeak (p=0.0017), SUVmean (p=0.0007), SUVIbm (p=0.0002), and SUVbsa (p=0.0005) in lesions with higher [68Ga]Ga-PSMA-11 SUV. Similarly, significant differences were observed in liver SUVmax (p<0.0001), SUVpeak (p<0.0001), and SUVmean (p<0.0001), with higher values for 18F-PSMA-1007. T/B (p<0.0001) and TL-PSMA (p=0.0063) also exhibited significantly higher [68Ga]Ga-PSMA-11 values.
Conclusion:
Consistent, predictable, and significant differences were observed in 18F-PSMA-1007 and [68Ga]Ga-PSMA-11 PET scans of lesion, liver, volume surrogates, supporting tracer interchangeability for patients with suspected prostate cancer. Our results also support the recent commissioning of PSMA-based PET tracers in England.
More Related Videos
12:01PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke
Published on: June 14, 2018
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
What is an Experiment?
Cancers Originate from Somatic Mutations in a Single Cell
Thomson's e/m Experiment
A particle with charge q, speed v, and mass m enters an area from the top, where the magnetic and electric fields are perpendicular both to the particle's motion and to one another. The magnetic...